HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ortrud K Steinlein Selected Research

Frontal Lobe Epilepsy (Epilepsy, Supplementary Motor)

3/2016Nocturnal frontal lobe epilepsy caused by a mutation in the GATOR1 complex gene NPRL3.
12/2010Animal models for autosomal dominant frontal lobe epilepsy: on the origin of seizures.
8/2008Human nocturnal frontal lobe epilepsy: pharmocogenomic profiles of pathogenic nicotinic acetylcholine receptor beta-subunit mutations outside the ion channel pore.
1/2002Channelopathies can cause epilepsy in man.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ortrud K Steinlein Research Topics

Disease

12Epilepsy (Aura)
01/2014 - 03/2002
6Autosomal Dominant Nocturnal Frontal Lobe Epilepsy
01/2014 - 07/2007
4Frontal Lobe Epilepsy (Epilepsy, Supplementary Motor)
03/2016 - 01/2002
4Channelopathies
01/2014 - 04/2004
3Glioma (Gliomas)
11/2005 - 09/2002
3Benign Neonatal Epilepsy (Benign Familial Neonatal Convulsions)
07/2005 - 01/2002
2Neoplasms (Cancer)
09/2021 - 10/2003
2Sepsis (Septicemia)
09/2021 - 10/2017
2Seizures (Absence Seizure)
08/2014 - 07/2005
2Febrile Seizures (Febrile Seizure)
01/2014 - 07/2002
2Autosomal Dominant Lateral Temporal Lobe Epilepsy
11/2005 - 09/2002
2Congenital Myasthenic Syndromes (Myasthenia Gravis, Congenital)
09/2003 - 05/2003
2Apnea
05/2003 - 06/2002
1COVID-19
09/2021
1Pneumonia (Pneumonitis)
09/2021
1Bacterial Pneumonia
09/2021
1Renal Cell Carcinoma (Grawitz Tumor)
01/2018
1Blister (Bulla)
01/2018
1Septic Shock (Toxic Shock Syndrome)
10/2017
1Malformations of Cortical Development
03/2016
1Partial Epilepsies (Epilepsy, Partial)
03/2016
1Myoclonic Epilepsies (Myoclonic Encephalopathy)
01/2014
1Tuberculosis (Tuberculoses)
03/2013
1Lung Neoplasms (Lung Cancer)
01/2013
1Epileptic Syndromes
10/2011
1Convulsions benign familial neonatal dominant form
10/2011
1Inborn Genetic Diseases (Disease, Hereditary)
05/2007
1Generalized Epilepsy
08/2005
1Disease Progression
07/2005
1Neuroleptic Malignant Syndrome
08/2004
1Intellectual Disability (Idiocy)
11/2003
1Absence Epilepsy (Childhood Absence Epilepsy)
07/2002
1Temporal Lobe Epilepsy
05/2002
1Generalized Epilepsy with Febrile Seizures Plus
01/2002

Drug/Important Bio-Agent (IBA)

10Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
01/2014 - 01/2002
5Proteins (Proteins, Gene)FDA Link
09/2021 - 07/2002
5Ion Channels (Ion Channel)IBA
03/2016 - 03/2002
3Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA
10/2011 - 01/2002
3Cholinergic ReceptorsIBA
12/2010 - 09/2003
3Leucine (L-Leucine)FDA Link
11/2005 - 09/2002
2MicroRNAs (MicroRNA)IBA
09/2021 - 10/2017
2Biomarkers (Surrogate Marker)IBA
09/2021 - 10/2017
2Indicators and Reagents (Reagents)IBA
01/2018 - 10/2017
2Voltage-Gated Sodium ChannelsIBA
01/2014 - 01/2002
2Sodium Channels (Sodium Channel)IBA
01/2014 - 04/2004
2Pharmaceutical PreparationsIBA
08/2010 - 07/2005
2Choline O-Acetyltransferase (Choline Acetyltransferase)IBA
05/2003 - 06/2002
2GABA-A Receptors (GABA(A) Receptor)IBA
07/2002 - 01/2002
1ProgranulinsIBA
09/2021
1ProcalcitoninIBA
09/2021
1sortilinIBA
09/2021
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
09/2021
1Toll-Like Receptor 4IBA
09/2021
1Reactive Oxygen Species (Oxygen Radicals)IBA
08/2014
1Amino AcidsFDA Link
08/2008
1Acetylcholine (Acetylcholine Chloride)FDA Link
08/2008
1Immunoglobulin E (IgE)IBA
08/2005
1Protein Isoforms (Isoforms)IBA
08/2004
1Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA
08/2004
1Ligand-Gated Ion ChannelsIBA
06/2004
1SodiumIBA
04/2004
1Carbamazepine (Tegretol)FDA LinkGeneric
11/2003
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
11/2003
1gamma-Aminobutyric Acid (GABA)IBA
07/2002
1Leucine-Rich Repeat ProteinsIBA
05/2002

Therapy/Procedure

2Therapeutics
01/2008 - 04/2003